OxNASH Score Correlates with Histologic Features and Severity of Nonalcoholic Fatty Liver Disease

The TONIC trial: A step forward in treating pediatric nonalcoholic fatty liver disease

(2012) Naim Alkhouri et al.   HEPATOLOGY

Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: New evidence on the potential therapeutic mechanism

(2012) Claudia O. Zein et al.   HEPATOLOGY

Endpoints and clinical trial design for nonalcoholic steatohepatitis

(2011) Arun J. Sanyal et al.   HEPATOLOGY

Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents

(2011) Joel E. Lavine   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Systematic review of performance of non-invasive biomarkers in the evaluation of non-alcoholic fatty liver disease

(2011) Michael H. Miller et al.   LIVER INTERNATIONAL

The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis

(2010) Mustafa S. Ascha et al.   HEPATOLOGY

Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

(2010) Ariel E. Feldstein et al.   JOURNAL OF LIPID RESEARCH

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

(2010) Arun J. Sanyal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Liver biopsy

(2008) Don C. Rockey et al.   HEPATOLOGY

Relationship of Paraoxonase 1 (PON1) Gene Polymorphisms and Functional Activity With Systemic Oxidative Stress and Cardiovascular Risk

(2008) Tamali Bhattacharyya   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION